SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Serapha Bio Reports Positive Interim SERP-01 Trial Data

The company said a single administration of SERP-01 was associated with increased total serum AAT above the protective threshold. Interim safety and efficacy data were presented at the ERS Alpha-1 Antitrypsin Conference 2026.

Related stories